Transgenic mdx mice expressing dystrophin with a deletion in the actin- binding domain display a 'mild Becker' phenotype

Journal of Cell Biology

Volumn 134, Issue 4, 1996, Pages 873-884

  Corrado, Kathleen ^a   Rafael, Jill A ^b   Mills, Patti L ^b   Cole, Neil M ^b   Faulkner, John A ^b   Wang, Kuan ^a   Chamberlain, Jeffrey S ^b  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN BINDING PROTEIN; COMPLEMENTARY DNA; DYSTROPHIN;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BECKER MUSCULAR DYSTROPHY; GENE DELETION; HISTOLOGY; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TRANSGENE; TRANSGENIC MOUSE;

ANIMALIA; MUS MUSCULUS;

EID: 0029825063     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.134.4.873     Document Type: Article

References (65)

1. Ahn, A.H., and L.M. Kunkel. 1993. The structural and functional diversity of dystrophin. Nat. Genet. 3:283-291.
2. Amalfitano A., J. A. Rafael, and J.S. Chamberlian. 1996. Dystrophin gene structure and mutation. In Dystrophin: Gene. Protein and Cell Biology. J. Lucy and S. Brown, editors. Cambridge University Press, Cambridge. In press.
3. Baumbach, L.L. J.S. Chamberlain, P.A. Ward, N.J. Farwell, and C.T. Caskey. 1989. Molecular and clinical correlations of deletions leading to Duchenne and Becker muscular dystrophies. Neurology. 39:465-474.
4. Beggs, A.M., E.P. Hoffman, J.R. Snyder, K. Arahata, L. Specht, F. Shapiro, C. Angelini, H. Sugita, and L.M. Kunkel. 1991. Exploring the molecular basis for variability among patients with Becker muscular dystrophy: dystrophin gene and protein studies. Am. J. Hum. Genet. 49:54-67.
5. Belkin, A.M., and K. Burridge. 1995. Association of aciculin with Dystrophin and Utrophin. J. Biol. Chem. 270:6328-6337.
6. Bonet-Kerrache, A., E. Fabbrizio, and D. Mornet. 1994. N-terminal domain of dystrophin. FEBS Lett. 355:49-53.
7. 3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex. Nature Genet. 11:266-273.
8. Bulfield, G., W.G. Siller, P.A. Wight, and K.J. Moore. 1984. X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc. Natl. Acad. Sci. USA. 81:1189-1192.
9. Bushby, K.M.D. 1992. Genetic and clinical correlations of Xp21 muscular dystrophy. J. Inherited Metab. Dis. 15:551-564.
10. Campbell, K.P. 1995. Three muscular dystrophies: loss of cytoskeleton-extracellular matrix linkage. Cell. 80:675-679.
11. Chelly, J., H. Gilgenkrantz, M. Lambert, G. Hammard, P. Chafey, D. Recan, P. Katz, et al. 1990. Effect of dystrophin gene deletions on mRNA levels and processing in Duchenne and Becker muscular dystrophies. Cell. 63:1239-1248.
12. Comi, G.P., A. Prelle, N. Bresolin, M. Moggio, A. Bardoni, A. Gallanti, G. Vita, A. Toscano, M.T. Ferro, A. Bordoni, et al. 1994. Clinical variability in Becker muscular dystrophy. Genetic biochemical and immunohistochemical correlates. Brain. 117:1-14.
13. Corrado, K., P.L. Mills, and J.S. Chamberlain. 1994. Deletion analysis of the dystrophin actin binding domain. FEBS Lett. 344:255-260.
14. Cox, G.A., Y. Sunada, K.P. Campbell, and J.S. Chamberlain. 1994. Dp71 can restore the dystrophin-associated glycoprotein complex in muscle but fails to prevent dystrophy. Nature Genet. 8:333-339.
15. Cox, G.A., N.M. Cole, K. Matsumura, S.F. Phelps, S.D. Hauschka, K.P. Campbell, J.A. Faulkner, and J.S. Chamberlain. 1993. Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity. Nature (Lond.). 364:725-729.
16. Dickson, G., A. Azad, G.E. Morris, H. Simon, M. Noursadeghi, and F.S. Walsh. 1992. Co-localization and molecular association of dystrophin with laminin at the surface of mouse and human myotubes. J. Cell Sci. 103:1223-1233.
17. Dunckley, M.G., K.E. Wells, T.A. Piper, D.J. Wells, and G. Dickson. 1994. Independent localization of dystrophin N- and COOH-terminal regions to the sarcolemma of mdx mouse myofibers in vivo. J. Cell Sci. 107:1469-1475.
18. Emery, A.E.H. 1993. Duchenne Muscular Dystrophy. Oxford Monographs on Medical Genetics Vol. 24. Oxford Medical Publications, Oxford, UK. 392 pp.
19. Ervasti, J.M., and K.P Campbell. 1991. Membrane organization of the dystrophin-glycoprotein complex. Cell. 66:1121-1131.
20. Ervasti, J.M., and K.P. Campbell. 1993. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J. Cell Biol. 122:809-823.
21. Fabbrizio, E., A. Bonet-Kerrache, J.J. Leger, and D. Mornet. 1993. Actin-dystrophin interface. Biochemistry. 32:10457-10463.
22. Helliwell, T.R., J.M. Ellis, R.C. Mountford, R.E. Appleton, and G.E. Morris. 1992. A truncated dystrophin lacking the COOH-terminal domain is localized at the muscle membrane. Am. J. Hum. Genet. 50:508-514.
23. Hoffman, E.P., C.A. Garcia, J.S. Chamberlain, C. Angelini, J.R. Lupski, and R. Fenwick. 1991. Is the carboxyl-terminus of dystrophin required for membrane association? A novel, severe case of Duchenne muscular dystrophy. Ann. Neurol. 30:605-610.
24. Hogan, B., F. Constantini, and E. Lacey. 1986. Manipulating the Mouse Embryo: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. 332 pp.
25. Hori, S., S. Ohtani, N. thi Man, and G.E. Morris. 1995. The N-terminal half of dystrophin is protected from proteolysis in situ. Biochem. Biophys. Res. Commun. 209:1062-1067.
26. Jarrett, H.W., and J.L. Foster. 1995. Alternate binding of actin and calmodulin to multiple sites on dystrophin. J. Biol. Chem. 270:5578-5586.
27. Johnson, J.E., B.J. Wold, and S.D. Hauschka. 1989. Muscle creatine kinase sequence elements regulating skeletal and cardiac muscle expression in transgenic mice. Mol. Cell Biol. 9:3393-3399.
28. Khyse-Anderson, J. 1984. Electroblotting of multiple gels: a simple apparatus without buffer tank for rapid transfer of proteins from polyacrylamide to nitrocellulose. J. Biochem. Biophys. Methods. 10:203-209.
29. Koenig, M., and L.M. Kunkel. 1990. Detailed analysis of the repeat domain of dystrophin reveals four potential hinge segments that may confer flexibility. J. Biol. Chem. 265:4560-4566.
30. Koenig, M., A.M. Beggs, M. Moyer, S. Scherpf, K. Heindrich, T. Bettecken, G. Meng, C.R. Muller, M. Lindlof, H. Kaariainen, et al. 1989. The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. Am. J. Hum Genet. 45:498-506.
31. Koenig, M., E.P. Hoffman, C.J. Bertelson, A.P. Monaco, C. Feener, and L.M. Kunkel. 1987. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell. 50:509-517.
32. Lee, C.C., J.A. Pearlman, J.S. Chamberlain, and C.T. Caskey. 1991. Expression of recombinant dystrophin and its localization to the cell membrane. Nature (Lond.). 349:334-336.
33. Levine, B.A., A.J.G. Moir, V.B. Patchell, and S.V. Perry. 1990. The interaction of actin with dystrophin. FEBS Lett. 263:159-162.
34. Levine, B.A., A.J.G. Moir, V.B. Patchell, and S.V. Perry. 1992. Binding sites involved in the interaction of actin with the N-terminal region of dystrophin. FEBS Lett. 298:44-48.
35. Lim, L.E., F. Duclos, O. Broux, N. Bourg, Y. Sunada, V. Allamand, J. Meyer, I.Z. Richard, C. Moomaw, C. Slaughter, F.M.S. Tomé, M. Fardeau, C.E. Jackson, J.S. Beckmann, and K.P. Campbell. 1995. β-Sarcoglycan: characterization and role in limb-girdle muscular dystrophy linked to 4q12. Nature Genet. 11:257-265.
36. Madhaven, R., and H.W. Jarrett. 1994. Calmodulin-activated phosphorylation of dystrophin. Biochemistry. 33:5797-5804.
37. Malhotra, S.B., K.A. Hart, H.J. Klamut, N.S.T. Thomas, S.E. Bodrug, A.H.M. Burghes, M. Bobrow, P.S. Harper, M.W. Thompson, P.N. Ray, et al. 1988. Frame-shift deletions in patients with Duchenne and Becker muscular dystrophy. Science (Wash. DC). 242:755-759.
38. Masuda, T., N. Fujimaki, E. Ozawa, and H. Ishikawa. 1992. Confocal laser microscopy of dystrophin localization in guinea pig skeletal muscle fibers. J. Cell Biol. 119:543-548.
39. Matsumura, K., F.M.S. Tomé, V. Ionasescu, J.M. Ervasti, R.D. Anderson, N.B. Romero, D. Simon, D. Récan, J.-C. Kaplan, M. Fardeau, et al. 1993. Deficiency of dystrophin-associated proteins in Duchenne muscular dystrophy patients lacking COOH-terminal domains of dystrophin. J. Clin. Invest. 92: 866-871.
40. McCully, K.K., and J.A. Faulkner. 1984. Length-tension relationship of mammalian diaphragm muscles. J. Appl. Physiol. 54:1681-1686.
41. Milot, E., P. Fraser, and F. Grosveld. 1996. Position effects and genetic disease. Trends Genet. 12:123-126.
42. Minnetti, C., F. Beltrame, G. Marcenaro, and E. Bonilla. 1992. Dystrophin at the plasma membrane of human muscle fibers shows a costameric localization. Neuromusc. Disord. 2:99-109.
43. Monaco, A.P., C.J. Bertelson, S. Liechti-Gallati, H. Moser, and L.M. Kunkel. 1988. An explanation for the phenotypic differences between patients bearing deletions of the DMD locus. Genomics 2:90-95.
44. Muntoni, F., P. Gobbi, C. Sewry, T. Sherrat, J. Taylor, S.K. Sandhu, S. Abbs, R. Roberts, S.V. Hodgson, M. Bobrow, et al. 1994. Deletions in the 5′ region of dystrophin and resulting phenotypes. J. Med. Genet. 31:843-847.
45. Noguchi, S., E.M. McNally, K. Ben Othmane, Y. Hagiwara, Y. Mizuno, M. Yoshida, H. Yamamoto, C.G. Bönnemann, E. Gussoni, P.H. Denton, et al. 1995. Mutations in the dystrophin-associated protein γ-sarcoglycan in chromosome 13 muscular dystrophy. Science (Wash. DC). 270:819-822.
46. Phelps, S.F., M.A. Hauser, N.M. Cole, J.A. Rafael. R.T. Hinkle, J.A. Faulkner, and J.S. Chamberlain. 1995. Expression of full-length and truncated dystrophin mini-genes in transgenic mdx mice. Hum. Mol. Genet. 4:1251-1258.
47. Porter, G.A., G.M. Dmytrenko, J.C. Winkelmann, and R.J. Bloch. 1992. Dystrophin colocalizes with β-spectrin in distinct subsarcolemmal domains in mammalian skeletal muscle. J. Cell Biol. 117:997-1005.
48. Rafael, J.A., G.A. Cox, K. Corrado, D. Jung, K.P. Campbell, and J.S. Chamberlain. 1996. Forced expression of dystrophin deletion constructs reveals structure-function correlations. J. Cell Biol. 134:93-102.
49. Rafael, J.A., Y. Sunada, N.M. Cole, K. Campbell, J.A. Faulkner, and J.S. Chamberlain. 1994. Prevention of dystrophic pathology in mdx mice by a truncated dystrophin isoform. Hum. Mol. Genet. 3:1725-1733.
50. Roberds, S.L., F. Leturcq, V. Allamand, F. Piccolo, M. Jeanpierre, R.D. Anderson, L.E. Lim, J.C. Lee, F.M. Tome, N.B. Romero, et al. 1994. Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophy. Cell. 78:625-633.
51. Roberts, R.G., R.J. Gardner, and M. Bobrow. 1994. Searching for the 1 in 2,400,000: a review of dystrophin gene point mutations. Hum. Mutal. 4:1-11.
52. Senter, L., M. Luise, C. Presotto, R. Betto, A. Teresi, S. Ceoldo, and G. Salviati. 1993. Interaction of dystrophin with cytoskeletal proteins: binding to talin and actin. Biochem. Biophys. Res. Commun. 192:899-904.
53. Senter, L., S. Ceoldo, M. Meznaric Petrusa, and G. Salviati. 1995. Phosphorylation of dystrophin: effects on actin binding. Biochem. Biophys. Res. Commun. 206:57-63.
54. Stedman, H.H., H.L. Sweeney, J.B. Shrager, H.C. Maguire, R.A. Panettieri, B. Petrof, M. Narusawa, J.M. Leferovich, J.T. Sladky, and A.M. Kelly. 1991. The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature (Lond.). 352:536-539.
55. Straub, V., R.E. Bittner, J.J. Leger, and T. Voit. 1992. Direct visualization of the dystrophin network on skeletal muscle fiber membrane. J. Cell Biol. 119: 1183-1191.
56. Thanh, L.T., N. thi Man, D.R. Love, T.R. Helliwell, K.E. Davies, and G.E. Morris. 1993. Monoclonal antibodies against the muscle-specific N-terminus of dystrophin: characterization of dystrophin in a muscular dystrophy patient with a frameshift deletion of exons 3-7. Am. J. Hum. Genet. 53:131-139.
57. Tome, F.M., T. Evangelista, A. Leclerc, Y. Sunada, E. Manole, B. Estournet, A. Barois, K.P. Campbell, and M. Fardeau. 1994. Congenital muscular dystrophy with merosin deficiency. C. R. (Comptes Rendus) Acad. Sci. 111 (Paris). 317:351-357.
58. Torres, L.F., and L.W. Duchen. 1987. The mutant mdx: inherited myopathy in the mouse. Morphological studies of nerves, muscles and end-plates. Brain. 110:269-299.
59. Wang, K., O.F. Bradford, C.A. Guyer, and J.V. Staros. 1989. Electrophoretic transfer of high molecular weight proteins for immunostaining. Methods Enzymol. 172:687-696.
60. Way, M., B. Pope, R.A. Cross, J. Kendrick-Jones, and A.G. Weeds. 1992. Expression of the N-terminal domain of dystrophin in E. coli and demonstration of binding to F-actin. FEBS Lett. 301:243-245.
61. Wells, D.J., K.E. Wells, E.A. Asante, G. Turner, Y. Sunada, K.P. Campbell, F.S. Walsh, and G. Dickson. 1995. Expression of human full-length and minidystrophin in transgenic mdx mice: implications for gene therapy of Duchenne muscular dystrophy. Hum. Mol. Genet. 4:1245-1250.
62. 2-terminal F-actin binding domain of utrophin. FEBS Lett. 357:125-128.
63. Winnard, A.V., C.J. Klein, D.D. Coovert, T. Prior, A. Papp, P. Snyder, D.E. Bulman, P.N. Ray, P. McAndrew, W. King, et al. 1993. Characterization of translational frame exception patients in Duchenne/Becker muscular dystrophy. Hum. Mol. Genet. 2:737-744.
64. Winnard, A.V., J.R. Mendell, T.W. Prior, J. Florence, and A.H.M. Burghes. 1995. Frameshift deletions of exons 3-7 and revertant fibers in Duchenne muscular dystrophy: mechanisms of dystrophin production. Am. J. Hum. Genet. 56:158-165.
65. Zubrzycka-Gaarn, E.E., D.E. Bulman, G. Karpati, A.H.M. Burghes, B. Belfall, H.J. Klamut, J. Talbot, R.S. Hodges, P.N. Ray, and R.G. Worton. 1988. The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle. Nature (Lond.). 333:466-469.